top of page
purpleDx background.png

Introducing...

purpleDx _ Primary Logo.png

electronRx are digital biomarker specialists dedicated to respiratory health. Our technology deciphers dynamic digital biomarkers from mobile device sensors, transforming them into impactful, actionable clinical insights.

​

purpleDx is a cardiopulmonary assessment device built to medical-grade standards, enabling patients to measure lung function leading to enhanced patient outcomes.

​

purpleDx: Medical Grade Digital Biomarker Solution

Captures the physiological cardiopulmonary metrics :

oDx heart circle.png

Heart Rate

oDx lung circle.png

Respiratory Rate

tidal volume.png

Tidal Volume

Why purpleDx?

Doctor Dashboard (1).png
home.png

Self monitoring at home

scalable technology.png

Scalable technology to measure lung function

medical device.png

Engineered to medical device standards

dashboard.png

Clinical dashboard showcasing patient metrics 

respiratory clinics.png

Developed with respiratory clinics

doctor on dashboard.png

purpleDx: Clinical Innovation

purpleDx is a medical tool, with potential applications in detecting, monitoring, and treating pulmonary diseases. This device aims to improve patient outcomes and optimise drug efficacy.

​

Integrating digital biomarker monitoring with prescribed medications embodies a progressive approach to healthcare management. purpleDx's cutting-edge technology allows healthcare providers to gain access to real-time physiological data via the clinical dashboard. Enabling clinicians to customise patient treatment plans, resulting in improved treatment results.

Meet the Team - Andy.png

Dr. Andy Potter​

Whaddon Medical Centre

​

“Emerging technologies offer promising solutions for better asthma management. These tools can help identify patients at risk of severe asthma attacks, enabling timely interventions and reducing hospital admissions”

New Website (1).png

To join our mission,

Get In Touch

Thanks! We'll be in touch soon.

electronRx partner with healthcare providers, payers and pharmaceutical companies across the globe, harnessing the power of digital biomarkers to manage breathing disorders effectively.

bottom of page